| Literature DB >> 25259845 |
Jeremie Vidal-Dupiol1, Nolwenn M Dheilly1, Rodolfo Rondon2, Christoph Grunau3, Céline Cosseau3, Kristina M Smith4, Michael Freitag4, Mehdi Adjeroud5, Guillaume Mitta3.
Abstract
Global change and its associated temperature increase has directly or indirectly changed the distributions of hosts and pathogens, and has affected host immunity, pathogen virulence and growth rates. This has resulted in increased disease in natural plant and animal populations worldwide, including scleractinian corals. While the effects of temperature increase on immunity and pathogen virulence have been clearly identified, their interaction, synergy and relative weight during pathogenesis remain poorly documented. We investigated these phenomena in the interaction between the coral Pocillopora damicornis and the bacterium Vibrio coralliilyticus, for which the infection process is temperature-dependent. We developed an experimental model that enabled unraveling the effects of thermal stress, and virulence vs. non-virulence of the bacterium. The physiological impacts of various treatments were quantified at the transcriptome level using a combination of RNA sequencing and targeted approaches. The results showed that thermal stress triggered a general weakening of the coral, making it more prone to infection, non-virulent bacterium induced an 'efficient' immune response, whereas virulent bacterium caused immuno-suppression in its host.Entities:
Mesh:
Year: 2014 PMID: 25259845 PMCID: PMC4178034 DOI: 10.1371/journal.pone.0107672
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Sequencing, filtering and gene expression analysis.
| Control | Non-virulent | Thermalstress | Virulent | Virulence (thermal stress vsvirulent treatment) | |
| Total reads (millions) | 27.7 | 20.4 | 17.0 | 19.3 | |
| Reads passing quality filter (millions) | 7.0 | 6.8 | 8.7 | 9.4 | |
| Predicted host transcriptome mapped reads | 88.4% | 85.2% | 87.3% | 81.6% | |
| Predicted symbiont transcriptome mapped reads | 79.9% | 78.0% | 79.5% | 75.8% | |
| Significantly up-regulated genes | 5,810 | 8,179 | 2.696 | 4.702 | |
| Significantly down-regulated genes | 3.543 | 13.342 | 14.166 | 11,299 | |
| Predicted host genes significantly up-regulated | 4713 | 3126 | 1578 | 4089 | |
| Predicted symbiont genes significantly up-regulated | 1097 | 5053 | 1118 | 613 | |
| Predicted host genes significantly down-regulated | 2401 | 11735 | 11382 | 5272 | |
| Predicted symbiont genes significantly down-regulated | 1142 | 1607 | 2784 | 6027 |
Figure 1Validation of the RNA-seq approach using q-RT-PCR.
Twenty-two genes were arbitrary selected, from highly up-regulated to highly down-regulated contigs. Their levels of expression were quantified by q-RT-PCR, and the results were compared with those obtained using the RNA-seq approach. The log2 changes in expression based on q-RT-PCR and RNA-seq analyses were closely correlated for all treatments, indicating the accuracy of the RNA-seq approach for quantification.
Biological functions significantly (p<0.05) enriched in the sets of up-regulated genes.
| Treatments | Non-virulent | Thermal stress | Virulent | Virulence | ||||
| GO Term | Up-regulated | Not-regulated | Up-regulated | Not-regulated | Up-regulated | Not-regulated | Up-regulated | Not-regulated |
| alcohol metabolic process | 20 | 91 | ||||||
| aromatic compound biosynthetic process | 6 | 9 | ||||||
| ATP synthesis coupled proton transport | 10 | 43 | ||||||
| bioluminescence | 6 | 10 | ||||||
| biosynthetic process | 64 | 899 | ||||||
| cellular amino acid biosynthetic process | 18 | 60 | ||||||
| cellular aromatic compound metabolic process | 10 | 46 | ||||||
| cellular component biogenesis | 27 | 109 | ||||||
| Cellular metabolic process | 190 | 2523 | ||||||
| Cellular protein modification process | 81 | 899 | ||||||
| cofactor metabolic process | 24 | 58 | ||||||
| fatty acid metabolic process | 7 | 15 | ||||||
| gene expression | 57 | 481 | ||||||
| generation of precursor metabolites and energy | 88 | 95 | 68 | 113 | 45 | 187 | ||
| heterocycle metabolic process | 59 | 261 | ||||||
| innate immune response | 10 | 45 | ||||||
| ion homeostasis | 7 | 23 | ||||||
| ion transport | 52 | 249 | ||||||
| macromolecular complex subunit organization | 25 | 86 | ||||||
| metabolic process | 726 | 3466 | 253 | 4022 | ||||
| microtubule-based process | 25 | 117 | ||||||
| nitrogen compound metabolic process | 127 | 833 | ||||||
| nucleoside phosphate metabolic process | 48 | 231 | ||||||
| nucleotide biosynthetic process | 19 | 119 | ||||||
| organic acid metabolic process | 43 | 202 | ||||||
| phosphorus metabolic process | 68 | 871 | ||||||
| phosphorylation | 57 | 411 | ||||||
| photosynthesis | 67 | 47 | 65 | 54 | 39 | 74 | ||
| protein stabilization | 3 | 0 | ||||||
| proton transport | 14 | 80 | ||||||
| regulation of gene expression | 5 | 12 | ||||||
| response to chemical stimulus | 7 | 39 | ||||||
| response to oxidative stress | 10 | 24 | 7 | 29 | ||||
| RNA processing | 14 | 69 | ||||||
| small molecule metabolic process | 119 | 499 | ||||||
| translation | 45 | 352 | ||||||
| transmembrane transport | 36 | 271 | 19 | 284 | ||||
Biological functions significantly (p<0.05) enriched in the sets of down-regulated genes.
| Treatments | Non-virulent | Thermal stress | Virulent | Virulence | ||||
| GO Term | Down-regulated | Not-regulated | Down-regulated | Not-regulated | Down-regulated | Not-regulated | Down-regulated | Not-regulated |
| apoptotic process | 15 | 33 | ||||||
| biological regulation | 162 | 646 | ||||||
| biosynthetic process | 66 | 881 | 232 | 702 | ||||
| cell surface receptor signaling pathway | 38 | 114 | ||||||
| cellular biosynthetic process | 186 | 662 | ||||||
| cellular component assembly at cellular level | 27 | 74 | 33 | 79 | ||||
| cellular component organization or biogenesis | 52 | 186 | 61 | 185 | ||||
| cellular macromolecule biosynthetic process | 165 | 394 | ||||||
| cellular macromolecule metabolic process | 337 | 1456 | ||||||
| cellular respiration | 16 | 42 | ||||||
| cellular response to stress | 7 | 68 | ||||||
| chromosome organization | 18 | 29 | 21 | 26 | ||||
| cofactor biosynthetic process | 13 | 33 | ||||||
| cofactor metabolic process | 25 | 59 | ||||||
| gene expression | 59 | 476 | 154 | 370 | 174 | 357 | ||
| generation of precursor metabolites and energy | 56 | 128 | ||||||
| glutamine metabolic process | 5 | 6 | ||||||
| hydrogen transport | 31 | 63 | ||||||
| immune response | 19 | 49 | 20 | 47 | ||||
| macromolecule metabolic process | 407 | 1758 | ||||||
| metabolic process | 220 | 4120 | ||||||
| microtubule-based process | 40 | 115 | ||||||
| neurotransmitter transport | 11 | 9 | 10 | 13 | ||||
| nitrogen compound metabolic process | 60 | 178 | ||||||
| nucleic acid metabolic process | 77 | 306 | ||||||
| nucleobase-containing compound catabolic process | 32 | 91 | ||||||
| organic acid transport | 8 | 12 | ||||||
| peptidyl-amino acid modification | 8 | 15 | ||||||
| phospholipid metabolic process | 9 | 20 | ||||||
| phosphorylation | 95 | 400 | ||||||
| photosynthesis | 37 | 38 | ||||||
| primary metabolic process | 524 | 2501 | 659 | 2422 | ||||
| protein folding | 47 | 108 | 46 | 113 | ||||
| protein metabolic process | 93 | 1790 | 337 | 1477 | 422 | 1421 | ||
| protein polymerization | 30 | 36 | ||||||
| protein targeting | 7 | 8 | 7 | 8 | ||||
| regulation of cell death | 12 | 22 | ||||||
| regulation of metabolic process | 25 | 65 | ||||||
| regulation of phosphate metabolic process | 12 | 21 | ||||||
| regulation of protein phosphorylation | 11 | 21 | ||||||
| response to DNA damage stimulus | 7 | 68 | ||||||
| response to stimulus | 153 | 640 | ||||||
| S-adenosylmethionine metabolic process | 2 | 9 | ||||||
| signaling | 113 | 442 | ||||||
| translation | 55 | 339 | 119 | 270 | 137 | 257 | ||
Biological functions significantly (p<0.05) enriched in the sets of up-regulated and down-regulated core genes.
| Regulation | Up-regulated | Down-regulated | ||
| GO Term | Up-regulated | Not-regulated | Down-regulated | Not-regulated |
| transmembrane transport | 7 | 299 | ||
| cellular biosynthetic process | 7 | 865 | ||
| localization | 7 | 873 | ||
| ATP biosynthetic process | 5 | 78 | ||
| cellular process | 66 | 4094 | ||
| primary metabolic process | 58 | 3079 | ||
| protein metabolic process | 38 | 1848 | ||
| biosynthetic process | 36 | 915 | ||
| gene expression | 32 | 503 | ||
| macromolecule biosynthetic process | 31 | 542 | ||
| translation | 30 | 364 | ||
| nucleic acid metabolic process | 11 | 417 | ||
| protein localization | 6 | 223 | ||
| cellular respiration | 4 | 54 | ||
| developmental process | 3 | 47 | ||
| protein targeting | 3 | 15 | ||
| sulfur compound biosynthetic process | 2 | 24 | ||
| cellular modified amino acid metabolic process | 2 | 29 | ||
| nucleoside biosynthetic process | 5 | 102 | ||
Figure 2Expression of innate immune candidate genes.
The data included q-RT-PCR results for nubbins sampled during the non-virulent, thermal stress, virulent and bacterial virulence (thermal stress vs. virulent treatment) treatments (days 3, 6, 9, 12, 15 and 18). Quantification was normalized to the control conditions for the non-virulent, thermal stress and virulent treatment, and with results for colonies sampled at the same temperature as that for the thermal stress vs. virulent comparison (bacterial virulence effect only). The results are presented as a log2-fold change in expression. The hierarchical clustering of the q-RT-PCR data was done using Multiple Array Viewer software (version 4.8.1), with average linkage clustering based on the Pearson correlation as a default distance metric. Cluster C1 represents the response to thermal stress, cluster C2 represents the response to bacteria (non-virulent and virulent), and cluster C3 represents the response to the virulence of the bacteria. The numbers at the bottom of the figure correspond to the following genes: 1, epsilon isoform 1 (housekeeping control); 2, MASP3; 3, peroxidase2; 4, peroxidase1; 5, cyclin d2 (housekeeping control); 6, preprotein translocase SecY subunit (housekeeping control); 7, laccase; 8, prophenol oxidase activating enzyme; 9, ubiquitin-conjugating enzyme E2 (housekeeping control); 10, 5-lypoxigenase; 11, catalase1; 12, nucleoredoxin; 13, TAK1; 14, MKK7; 15, MKK4; 16, JNK; 17, TRAF6; 18, IKBa; 19, NF-kB; 20, TIR2; 21, AP1; 22, ATF; 23, Bf; 24, C3; 25, MASP1; 26, catalase2; 27, MKK3/6; 28, IKK; 29, p38; 30, LRR2; 31, apextrin; 32, SOD1; 33, leukotriene A4 hydrolase; 34,Leukotriene C4 synthase; 35, MyD88; 36, GFP-Like2; 37, TIR3; 38, SOD2; 39, MEKK1; 40, LPBPI; 41, LRR-TIR-IGG; 42, GFP-Like1; 43, Tx60A2; 44, Tx60A1; 45, PdC-Lectin; 46,damicornin; 47, phospholipase A2; 48, mytimacin-like.
Figure 3Schematic representation of the innate immune pathways monitored by q-RT-PCR, and their main response to each treatment.
Reconstitution of the immune pathways identified in previous studies and from the present study (see Table 5 for references). Arrows highlight the average response (if any) of each pathway to each treatment or comparison. Green arrow: response to the non-virulent treatment; yellow arrow: response to the thermal stress treatment; red arrow: response to the virulent treatment; violet arrow: response to the virulence effect (the comparison between the thermal stress and the virulent treatment).
Summary of the cnidarian immune genes identified.
| Immune function | Gene/protein | References |
| Recognition | Lectins, integrins, Toll-like receptors |
|
| Signaling | NF- k B, AP1/ATF, JNK, Myd88, MAPKs |
|
| Complement | C3, mannose binding lectins, MASPs |
|
| Melanization | Laccase, phenoloxidase, prophenoloxidase |
|
| Antimicrobial activity | Hydramacin-1, Periculin1, Aurelin, Damicornin, LBP-BPI, mytimacin-like |
|
| Leukotriene cascade | Phospholipase A2, 5-lipoxigenase, leukotriene C4-synthase, leukotriene A4-hydrolase | This study |